Cellular immune responses to live attenuated Japanese Encephalitis (JE) vaccine SA14-14-2 in adults in a JE/dengue co-endemic area.
<h4>Background</h4> <p>Japanese encephalitis (JE) virus (JEV) causes severe epidemic encephalitis across Asia, for which the live attenuated vaccine SA14-14-2 is being used increasingly. JEV is a flavivirus, and is closely related to dengue virus (DENV), which is co-endemic in man...
Main Authors: | Turtle, L, Tatullo, F, Bali, T, Ravi, V, Soni, M, Chan, S, Chib, S, Venkataswamy, M, Fadnis, P, Yaïch, M, Fernandez, S, Klenerman, P, Satchidanandam, V, Solomon, T |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2017
|
Similar Items
-
Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area.
by: Lance Turtle, et al.
Published: (2017-01-01) -
Long-term immunogenicity of the SA14-14-2 Japanese encephalitis (JE) vaccine (CD.JEVAX®) booster following chimeric JE (IMOJEV®) vaccine priming in Thai children
by: Tawee Chotpitayasunondh, et al.
Published: (2024-12-01) -
Human T cell responses to Japanese encephalitis virus in health and disease
by: Turtle, L, et al.
Published: (2016) -
Editorial JeDEM Vol. 14, No. 1 (2022)
by: Anneke Zuiderwijk, et al.
Published: (2022-07-01) -
Editorial JeDEM Vol. 14, No. 1 (2022)
by: Anneke Zuiderwijk, et al.
Published: (2022-07-01)